nivolumab,ipilimumab
bms
['nsclc', 'sclc', 'increase,(-increased)']
interesting thoughts of about goals of management of invasive t3/4 nsclc in the discussion of increase trial of ct+rt+double it in neoadjuvant setting (81% of g3-4 aes in preoperative strategy call for caution) at 
Born in Majorca. Medical oncologist. Clinical researcher. Focused in lung cancer. World citizen. Major concerns: human inequality and blue planet environment